Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-05 Sale(A) | 2024-02-07 2:12 pm | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Foose Brice 10% Owner | 330,000 | $0.37282 | $123,030 | 0 (Direct) | View |
| 2023-02-05 Purchase | 2024-02-07 1:31 pm | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Foose Brice 10% Owner | 330,000 | $0.37282 | $123,030 | 0 (Direct) | View |
| 2020-03-10 Purchase | 2020-03-12 7:01 pm | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Toselli Richard M. See Remarks | 3,636 | $0 | $0 | 9,705 (Direct) | View |
| 2020-03-10 Purchase | 2020-03-12 7:01 pm | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | CHRISTOPHER RICHARD CFO and Treasurer | 3,636 | $0 | $0 | 8,856 (Direct) | View |
| 2020-03-10 Purchase | 2020-03-12 7:01 pm | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | MERRIFIELD C ANN Director | 3,636 | $0 | $0 | 7,275 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2023-04-24 3:26 pm | N/A N/A | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Foose Brice 10% Owner | 0 | $0 | 330,000 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:05 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | CHRISTOPHER RICHARD Chief Financial Officer | 20,800 | $0 | 20,800 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:04 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Toselli Richard M. CEO and CMO | 61,000 | $0 | 61,000 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:04 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | ROSENTHAL BOB Director | 4,200 | $0 | 4,200 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:03 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | ROBERTS RICHARD JOHN Director | 4,200 | $0 | 4,200 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:02 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Hamel Heather Chief Legal Officer and GC | 13,400 | $0 | 13,400 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:02 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | MARSHAK DANIEL R Director | 4,200 | $0 | 4,200 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:02 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | MERRIFIELD C ANN Director | 4,200 | $0 | 4,200 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-21 5:00 pm | N/A 2032-11-16 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Morrison Christina Director | 4,200 | $0 | 4,200 (Direct) | View |
Ownership | 2022-07-18 9:31 pm | N/A N/A | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Hamel Heather Chief Legal Officer and GC | 0 | $0 | 1,714 (Direct) | View |
| 2021-12-21 Tax Withholding | 2021-12-23 4:02 pm | N/A N/A | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Toselli Richard M. See Remarks | 16 | $0.54 | 6,201 (Direct) | View |
| 2021-06-21 Tax Withholding | 2021-06-23 8:52 pm | N/A N/A | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Toselli Richard M. See Remarks | 21 | $0.74 | 6,217 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 9:34 pm | N/A 2031-03-17 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | CHRISTOPHER RICHARD CFO and Treasurer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 9:33 pm | N/A 2031-03-17 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Toselli Richard M. See Remarks | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 9:33 pm | N/A 2031-03-17 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | MARSHAK DANIEL R Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 9:32 pm | N/A 2031-03-17 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Morrison Christina Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 9:32 pm | N/A 2031-03-17 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | ROBERTS RICHARD JOHN Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 9:31 pm | N/A 2031-03-17 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | ROSENTHAL BOB Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-22 9:30 pm | N/A 2031-03-17 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | MERRIFIELD C ANN Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-12-21 Tax Withholding | 2020-12-23 4:14 pm | N/A N/A | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Toselli Richard M. See Remarks | 16 | $0.6 | 6,238 (Direct) | View |
| 2020-06-19 Tax Withholding | 2020-06-23 6:35 pm | N/A N/A | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Toselli Richard M. See Remarks | 15 | $1.7 | 6,054 (Direct) | View |